Immune disease comorbidities

PheWeb

ASTHMA_IMMUNECOMORB

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries None

Check pre-conditions, main-only, mode, ICD version None

Check minimum number of events None

Include endpoints

K11_IBD

M13_SYSTCONNECT

K11_OTHENTERCOL

M13_RHEUMA

30367

ASTHMA_IMMUNECOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Immune disease comorbidities based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	29510	18722	10788
Unadjusted prevalence (%)	9.56	10.79	7.99
Mean age at first event (years)	48.97	47.71	51.17

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	1.98 [1.69, 2.33]	9.9e-17	2969
15 years	0.01	1.19 [1.01, 1.40]	3.5e-2	1284
5 years	0.00	2.32 [2.04, 2.64]	1.6e-37	768
1 year	0.00	5.98 [5.11, 6.99]	<1e-100	398

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: ASTHMA_IMMUNECOMORB – Immune disease comorbidities
GWS hits:

Survival analyses between endpoints

↥

Plot

before Immune disease comorbidities
after Immune disease comorbidities

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Immune disease comorbidities

↥